CIAM
ORKA icon

Caitong International Asset Management’s Oruka Therapeutics ORKA Stock Holding History

Caitong International Asset Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-910
Closed -$44.6K – 3517
2026
Q1 		$44.6K Sell
910
-1,304
-59% -$45.3K 0.01% 821
2025
Q4 		$67.1K Buy
+2,214
New +$61.7K 0.02% 590
2025
Q3 		– Sell
-1
Closed -$11 – 2613
2025
Q2 		$11 Buy
+1
New +$10 ﹤0.01% 1904

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Caitong International Asset Management's ORKA Position: Q2 2026 in Review

Caitong International Asset Management sold out of Oruka Therapeutics (ORKA) in Q2 2026, closing a stake of 910 shares — an estimated $44.6K sold.

Caitong International Asset Management first reported a position in ORKA in Q2 2025 and held it in 3 quarters. The position peaked at $67.1K in Q4 2025. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Caitong International Asset Management reported no remaining Oruka Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 910 Oruka Therapeutics shares in Q2 2026, an estimated $44.6K.
  • Caitong International Asset Management first reported a position in Oruka Therapeutics in Q2 2025 and held it in 3 quarters.
  • Caitong International Asset Management's Oruka Therapeutics position peaked at $67.1K in Q4 2025.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.